Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity.

Kuo TC, Chen CT, Baron D, Onder TT, Loewer S, Almeida S, Weismann CM, Xu P, Houghton JM, Gao FB, Daley GQ, Doxsey S.

Nat Cell Biol. 2011 Sep 11;13(10):1214-23. doi: 10.1038/ncb2332. Erratum in: Nat Cell Biol. 2011 Dec;13(12):1467.

2.

Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.

Mosca E, Cocola C, Sabour D, Pelucchi P, Bertalot G, Palumbo O, Carella M, Götte M, Schöler HR, Reinbold R, Zucchi I, Milanesi L.

In Silico Biol. 2010;10(5-6):207-21. doi: 10.3233/ISB-2010-0437.

PMID:
22430355
3.

Cohesin's role in pluripotency and reprogramming.

Gupta P, Lavagnolli T, Mira-Bontenbal H, Fisher AG, Merkenschlager M.

Cell Cycle. 2016;15(3):324-30. doi: 10.1080/15384101.2015.1128593. Epub 2015 Dec 23.

4.

Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell.

Nishi M, Akutsu H, Kudoh A, Kimura H, Yamamoto N, Umezawa A, Lee SW, Ryo A.

Oncotarget. 2014 Sep 30;5(18):8665-80.

5.

Cyclin A1 is essential for setting the pluripotent state and reducing tumorigenicity of induced pluripotent stem cells.

McLenachan S, Menchón C, Raya A, Consiglio A, Edel MJ.

Stem Cells Dev. 2012 Oct 10;21(15):2891-9. doi: 10.1089/scd.2012.0190. Epub 2012 Jun 25.

6.

Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis.

Fabbro M, Zhou BB, Takahashi M, Sarcevic B, Lal P, Graham ME, Gabrielli BG, Robinson PJ, Nigg EA, Ono Y, Khanna KK.

Dev Cell. 2005 Oct;9(4):477-88.

7.

Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.

Nagai K, Ishii H, Miyoshi N, Hoshino H, Saito T, Sato T, Tomimaru Y, Kobayashi S, Nagano H, Sekimoto M, Doki Y, Mori M.

Biochem Biophys Res Commun. 2010 Apr 30;395(2):258-63. doi: 10.1016/j.bbrc.2010.03.176. Epub 2010 Apr 7.

PMID:
20381452
8.

Roles of BCCIP in chromosome stability and cytokinesis.

Meng X, Fan J, Shen Z.

Oncogene. 2007 Sep 20;26(43):6253-60. Epub 2007 Apr 23.

9.

Interaction of Skp1 with CENP-E at the midbody is essential for cytokinesis.

Liu D, Zhang N, Du J, Cai X, Zhu M, Jin C, Dou Z, Feng C, Yang Y, Liu L, Takeyasu K, Xie W, Yao X.

Biochem Biophys Res Commun. 2006 Jun 23;345(1):394-402. Epub 2006 Apr 25.

PMID:
16682006
10.

Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.

Hoshino H, Nagano H, Haraguchi N, Nishikawa S, Tomokuni A, Kano Y, Fukusumi T, Saito T, Ozaki M, Sakai D, Satoh T, Eguchi H, Sekimoto M, Doki Y, Mori M, Ishii H.

Int J Oncol. 2012 May;40(5):1423-30. doi: 10.3892/ijo.2012.1346. Epub 2012 Jan 24.

PMID:
22293932
11.

Midbody ring disposal by autophagy is a post-abscission event of cytokinesis.

Pohl C, Jentsch S.

Nat Cell Biol. 2009 Jan;11(1):65-70. doi: 10.1038/ncb1813. Epub 2008 Dec 14.

PMID:
19079246
12.

Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis.

Morita E, Sandrin V, Chung HY, Morham SG, Gygi SP, Rodesch CK, Sundquist WI.

EMBO J. 2007 Oct 3;26(19):4215-27. Epub 2007 Sep 13. Erratum in: EMBO J. 2012 Jul 18;31(14):3228.

13.

Autophagy and cell reprogramming.

Wang S, Xia P, Rehm M, Fan Z.

Cell Mol Life Sci. 2015 May;72(9):1699-713. doi: 10.1007/s00018-014-1829-3. Epub 2015 Jan 9. Review.

PMID:
25572296
14.

Autophagic control of cell 'stemness'.

Pan H, Cai N, Li M, Liu GH, Izpisua Belmonte JC.

EMBO Mol Med. 2013 Mar;5(3):327-31. doi: 10.1002/emmm.201201999. Review.

15.

Centrosome-dependent exit of cytokinesis in animal cells.

Piel M, Nordberg J, Euteneuer U, Bornens M.

Science. 2001 Feb 23;291(5508):1550-3.

16.

Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells.

Klawitter S, Fuchs NV, Upton KR, Muñoz-Lopez M, Shukla R, Wang J, Garcia-Cañadas M, Lopez-Ruiz C, Gerhardt DJ, Sebe A, Grabundzija I, Merkert S, Gerdes P, Pulgarin JA, Bock A, Held U, Witthuhn A, Haase A, Sarkadi B, Löwer J, Wolvetang EJ, Martin U, Ivics Z, Izsvák Z, Garcia-Perez JL, Faulkner GJ, Schumann GG.

Nat Commun. 2016 Jan 8;7:10286. doi: 10.1038/ncomms10286.

17.

Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer.

Strauss R, Hamerlik P, Lieber A, Bartek J.

Mol Ther. 2012 May;20(5):887-97. doi: 10.1038/mt.2012.2. Epub 2012 Feb 7. Review.

18.

Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells.

Shah M, Allegrucci C.

Subcell Biochem. 2013;61:545-65. doi: 10.1007/978-94-007-4525-4_24. Review.

PMID:
23150267
19.

Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis.

Jeffery J, Sinha D, Srihari S, Kalimutho M, Khanna KK.

Oncogene. 2016 Feb 11;35(6):683-90. doi: 10.1038/onc.2015.128. Epub 2015 Apr 27. Review.

PMID:
25915844
20.

Genome-wide functional analysis reveals factors needed at the transition steps of induced reprogramming.

Yang CS, Chang KY, Rana TM.

Cell Rep. 2014 Jul 24;8(2):327-37. doi: 10.1016/j.celrep.2014.07.002. Epub 2014 Jul 17.

Supplemental Content

Support Center